FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011600512> ?p ?o ?g. }

• W3011600512 endingPage "150" @default.
• W3011600512 startingPage "140" @default.
• W3011600512 abstract "Background Type 2 diabetes (T2D) increases risk for cardiovascular disease. Of interest, liraglutide, a therapy for T2D that activates the glucagon-like peptide-1 receptor to augment insulin secretion, reduces cardiovascular-related death in people with T2D, though it remains unknown how liraglutide produces these actions. Notably, the glucagon-like peptide-1 receptor is not expressed in ventricular cardiac myocytes, making it likely that ventricular myocardium-independent actions are involved. We hypothesized that augmented insulin secretion may explain how liraglutide indirectly mediates cardioprotection, which thereby increases myocardial glucose oxidation. Methods C57BL/6J male mice were fed either a low-fat diet (lean) or were subjected to experimental T2D and treated with either saline or liraglutide 3× over a 24-hour period. Mice were subsequently euthanized and had their hearts perfused in the working mode to assess energy metabolism. A separate cohort of mice with T2D were treated with either vehicle control or liraglutide for 2 weeks for the assessment of cardiac function via ultrasound echocardiography. Results Treatment of lean mice with liraglutide increased myocardial glucose oxidation without affecting glycolysis. Conversely, direct treatment of the isolated working heart with liraglutide had no effect on glucose oxidation. These findings were recapitulated in mice with T2D and associated with increased circulating insulin levels. Furthermore, liraglutide treatment alleviated diastolic dysfunction in mice with T2D, which was associated with enhanced pyruvate dehydrogenase activity, the rate-limiting enzyme of glucose oxidation. Conclusions Our data demonstrate that liraglutide augments myocardial glucose oxidation via indirect mechanisms, which may contribute to how liraglutide improves cardiovascular outcomes in people with T2D." @default.
• W3011600512 created "2020-03-23" @default.
• W3011600512 creator A5003190574 @default.
• W3011600512 creator A5003760407 @default.
• W3011600512 creator A5024507895 @default.
• W3011600512 creator A5031525733 @default.
• W3011600512 creator A5037034855 @default.
• W3011600512 creator A5046567898 @default.
• W3011600512 creator A5059222562 @default.
• W3011600512 creator A5059889861 @default.
• W3011600512 creator A5061668188 @default.
• W3011600512 creator A5066035797 @default.
• W3011600512 creator A5083479575 @default.
• W3011600512 creator A5083733494 @default.
• W3011600512 date "2021-01-01" @default.
• W3011600512 modified "2023-09-26" @default.
• W3011600512 title "The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy" @default.
• W3011600512 cites W1965453788 @default.
• W3011600512 cites W1967442749 @default.
• W3011600512 cites W1980821438 @default.
• W3011600512 cites W1983483428 @default.
• W3011600512 cites W2013299013 @default.
• W3011600512 cites W2017820712 @default.
• W3011600512 cites W2035192492 @default.
• W3011600512 cites W2038523067 @default.
• W3011600512 cites W2048320533 @default.
• W3011600512 cites W2063400466 @default.
• W3011600512 cites W2065623326 @default.
• W3011600512 cites W2070647639 @default.
• W3011600512 cites W2070768644 @default.
• W3011600512 cites W2088417711 @default.
• W3011600512 cites W2093501112 @default.
• W3011600512 cites W2098822834 @default.
• W3011600512 cites W2102308209 @default.
• W3011600512 cites W2114671826 @default.
• W3011600512 cites W2117340025 @default.
• W3011600512 cites W2122167119 @default.
• W3011600512 cites W2128547859 @default.
• W3011600512 cites W2132593820 @default.
• W3011600512 cites W2146534889 @default.
• W3011600512 cites W2150012656 @default.
• W3011600512 cites W2163669042 @default.
• W3011600512 cites W2164671913 @default.
• W3011600512 cites W2164676964 @default.
• W3011600512 cites W2214416180 @default.
• W3011600512 cites W2284080609 @default.
• W3011600512 cites W2425644022 @default.
• W3011600512 cites W2469730409 @default.
• W3011600512 cites W2475233216 @default.
• W3011600512 cites W2505843168 @default.
• W3011600512 cites W2594856498 @default.
• W3011600512 cites W2612056900 @default.
• W3011600512 cites W2766733580 @default.
• W3011600512 cites W2789513498 @default.
• W3011600512 cites W2791027285 @default.
• W3011600512 cites W2792805849 @default.
• W3011600512 cites W2806521060 @default.
• W3011600512 cites W2883773944 @default.
• W3011600512 cites W2892247024 @default.
• W3011600512 cites W2959149279 @default.
• W3011600512 cites W2990856521 @default.
• W3011600512 cites W4234623574 @default.
• W3011600512 cites W770877583 @default.
• W3011600512 doi "https://doi.org/10.1016/j.cjca.2020.02.098" @default.
• W3011600512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32640211" @default.
• W3011600512 hasPublicationYear "2021" @default.
• W3011600512 type Work @default.
• W3011600512 sameAs 3011600512 @default.
• W3011600512 citedByCount "30" @default.
• W3011600512 countsByYear W30116005122020 @default.
• W3011600512 countsByYear W30116005122021 @default.
• W3011600512 countsByYear W30116005122022 @default.
• W3011600512 countsByYear W30116005122023 @default.
• W3011600512 crossrefType "journal-article" @default.
• W3011600512 hasAuthorship W3011600512A5003190574 @default.
• W3011600512 hasAuthorship W3011600512A5003760407 @default.
• W3011600512 hasAuthorship W3011600512A5024507895 @default.
• W3011600512 hasAuthorship W3011600512A5031525733 @default.
• W3011600512 hasAuthorship W3011600512A5037034855 @default.
• W3011600512 hasAuthorship W3011600512A5046567898 @default.
• W3011600512 hasAuthorship W3011600512A5059222562 @default.
• W3011600512 hasAuthorship W3011600512A5059889861 @default.
• W3011600512 hasAuthorship W3011600512A5061668188 @default.
• W3011600512 hasAuthorship W3011600512A5066035797 @default.
• W3011600512 hasAuthorship W3011600512A5083479575 @default.
• W3011600512 hasAuthorship W3011600512A5083733494 @default.
• W3011600512 hasConcept C126322002 @default.
• W3011600512 hasConcept C134018914 @default.
• W3011600512 hasConcept C170493617 @default.
• W3011600512 hasConcept C185280430 @default.
• W3011600512 hasConcept C2777180221 @default.
• W3011600512 hasConcept C2778938600 @default.
• W3011600512 hasConcept C2779306644 @default.
• W3011600512 hasConcept C2779676291 @default.
• W3011600512 hasConcept C2781308992 @default.
• W3011600512 hasConcept C500558357 @default.
• W3011600512 hasConcept C555293320 @default.
• W3011600512 hasConcept C71924100 @default.

• next